182 related articles for article (PubMed ID: 33602035)
21. Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults.
Isturiz R; Grant L; Gray S; Alexander-Parrish R; Jiang Q; Jodar L; Peyrani P; Ford KD; Pride MW; Self WH; Counselman F; Volturo G; Ostrosky-Zeichner L; Wunderink RG; Sherwin R; Overcash JS; File T; Ramirez J
Clin Infect Dis; 2021 Oct; 73(7):1216-1222. PubMed ID: 33982098
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design.
McLaughlin JM; Jiang Q; Isturiz RE; Sings HL; Swerdlow DL; Gessner BD; Carrico RM; Peyrani P; Wiemken TL; Mattingly WA; Ramirez JA; Jodar L
Clin Infect Dis; 2018 Oct; 67(10):1498-1506. PubMed ID: 29790925
[TBL] [Abstract][Full Text] [Related]
23. Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines.
Principi N; Esposito S
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28029140
[TBL] [Abstract][Full Text] [Related]
24. Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years.
Greenberg D; Givon-Lavi N; Ben-Shimol S; Ziv JB; Dagan R
Vaccine; 2015 Aug; 33(36):4623-9. PubMed ID: 26116251
[TBL] [Abstract][Full Text] [Related]
25. Surveillance of pneumococcal serotypes in adults hospitalised with acute lower respiratory tract infection in Bristol, UK.
Hyams C; Lahuerta M; Theilacker C; King J; Adegbite D; McGuinness S; Grimes C; Campling J; Southern J; Pride MW; Begier E; Maskell N; Oliver J; Jodar L; Gessner BD; Finn A;
Vaccine; 2024 Mar; 42(7):1599-1607. PubMed ID: 38336560
[TBL] [Abstract][Full Text] [Related]
26. Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children.
Angoulvant F; Levy C; Grimprel E; Varon E; Lorrot M; Biscardi S; Minodier P; Dommergues MA; Hees L; Gillet Y; Craiu I; Zenkhri F; Dubos F; Guen CG; Launay E; Martinot A; Cohen R
Clin Infect Dis; 2014 Apr; 58(7):918-24. PubMed ID: 24532543
[TBL] [Abstract][Full Text] [Related]
27. Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age.
Isturiz RE; Hall-Murray C; McLaughlin JM; Snow V; Schmoele-Thoma B; Webber C; Thompson A; Scott DA
Expert Rev Vaccines; 2018 Jan; 17(1):45-55. PubMed ID: 29183235
[TBL] [Abstract][Full Text] [Related]
28. Incidence, aetiology and serotype coverage for pneumococcal vaccines of community-acquired pneumonia in adults: a population-based prospective active surveillance study in Brazil.
Duarte FG; Barberino MG; da Silva Moreira S; Reis JN; Spinardi JR; de Almeida RS; Allen KE; Alexander-Parrish R; Brim R; de Araújo Neto CA; Moreira ED
BMJ Open; 2022 Apr; 12(4):e059824. PubMed ID: 35428648
[TBL] [Abstract][Full Text] [Related]
29. Pneumococcal conjugate vaccine use in adults - Addressing an unmet medical need for non-bacteremic pneumococcal pneumonia.
Sings HL
Vaccine; 2017 Sep; 35(40):5406-5417. PubMed ID: 28602602
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of community-acquired pneumonia in the era of extended serotype-covering multivalent pneumococcal conjugate vaccines.
Heo JY; Seo YB; Jeong HW; Choi MJ; Min KH; Choi WS; Lee J; Noh JY; Cheong HJ; Kim WJ; Song JY
Vaccine; 2020 Nov; 38(49):7747-7755. PubMed ID: 33164798
[TBL] [Abstract][Full Text] [Related]
31. Impact of pneumococcal vaccination in children on serotype distribution in adult community-acquired pneumonia using the serotype-specific multiplex urinary antigen detection assay.
Pletz MW; Ewig S; Rohde G; Schuette H; Rupp J; Welte T; Suttorp N; Forstner C;
Vaccine; 2016 Apr; 34(20):2342-8. PubMed ID: 27016653
[TBL] [Abstract][Full Text] [Related]
32. Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010-2015.
Silva-Costa C; Brito MJ; Pinho MD; Friães A; Aguiar SI; Ramirez M; Melo-Cristino J; ;
Emerg Infect Dis; 2018 Jul; 24(7):1307-1314. PubMed ID: 29912700
[TBL] [Abstract][Full Text] [Related]
33. Theory and strategy for Pneumococcal vaccines in the elderly.
Namkoong H; Ishii M; Funatsu Y; Kimizuka Y; Yagi K; Asami T; Asakura T; Suzuki S; Kamo T; Fujiwara H; Tasaka S; Betsuyaku T; Hasegawa N
Hum Vaccin Immunother; 2016; 12(2):336-43. PubMed ID: 26406267
[TBL] [Abstract][Full Text] [Related]
34. Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN).
LeBlanc JJ; ElSherif M; Ye L; MacKinnon-Cameron D; Ambrose A; Hatchette TF; Lang ALS; Gillis HD; Martin I; Demczuk W; Andrew MK; Boivin G; Bowie W; Green K; Johnstone J; Loeb M; McCarthy AE; McGeer A; Semret M; Trottier S; Valiquette L; Webster D; McNeil SA
Vaccine; 2019 Aug; 37(36):5466-5473. PubMed ID: 31345638
[TBL] [Abstract][Full Text] [Related]
35. Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel.
Regev-Yochay G; Chowers M; Chazan B; Gonzalez E; Gray S; Zhang Z; Pride M
Hum Vaccin Immunother; 2018; 14(10):2527-2532. PubMed ID: 30188760
[TBL] [Abstract][Full Text] [Related]
36. Direct and indirect effects of the 13-valent pneumococcal conjugate vaccine administered to infants and young children.
Esposito S; Principi N;
Future Microbiol; 2015; 10(10):1599-607. PubMed ID: 26439470
[TBL] [Abstract][Full Text] [Related]
37. Effects of 13-valent pneumococcal conjugate vaccination of adults on lower respiratory tract infections and antibiotic use in primary care: secondary analysis of a double-blind randomized placebo-controlled study.
van Werkhoven CH; Bolkenbaas M; Huijts SM; Verheij TJM; Bonten MJM
Clin Microbiol Infect; 2021 Jul; 27(7):995-999. PubMed ID: 32971253
[TBL] [Abstract][Full Text] [Related]
38. Pneumococcal vaccines and the prevention of community-acquired pneumonia.
Esposito S; Principi N
Pulm Pharmacol Ther; 2015 Jun; 32():124-9. PubMed ID: 24607597
[TBL] [Abstract][Full Text] [Related]
39. The potential role of 13-valent pneumococcal conjugate vaccine in preventing respiratory complications in bacteraemic pneumococcal community-acquired pneumonia.
Sanz-Herrero F; Gimeno-Cardona C; Tormo-Palop N; Fernández-Fabrellas E; Briones ML; Cervera-Juan Á; Blanquer-Olivas J
Vaccine; 2016 Apr; 34(15):1847-52. PubMed ID: 26845737
[TBL] [Abstract][Full Text] [Related]
40. Pneumococcal diagnosis and serotypes in childhood community-acquired pneumonia.
Elemraid MA; Sails AD; Thomas MF; Rushton SP; Perry JD; Eltringham GJ; Spencer DA; Eastham KM; Hampton F; Gennery AR; Clark JE;
Diagn Microbiol Infect Dis; 2013 Jun; 76(2):129-32. PubMed ID: 23537785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
